Skip to content
AwardedSpainGoods

Suministro de Medicamentos con principio activo Eculizumab para el tratamiento de la Hemoglobinuria Paroxística Nocturna y Síndrome Hemolítico Urémico con destino a Centros Sanitarios dependientes del Servicio Murciano de Salud.

Published
Published 10 June 2025

Overview

Suministro de Medicamentos con principio activo eculizumab para el tratamiento de la Hemoglobinuria Paroxística Nocturna y Síndrome Hemolítico Urémico c

Key details

Country
Spain
Status
Awarded
Category
Goods
Procedure
Open
Published
10 June 2025
Classification (CPV)
Immunosuppressive agents

Award outcome

Awarded value
€1,865,500
Award date
6 May 2025
Winner
  • 2 adjudicatarios AMGEN S.A.: 1911000 y SAMSUNG BIOEPIS NL B.V:1820000

Contract ending soon? Skim tracks incumbents and flags recompetes early. Book a demo to set up alerts.

Notice history

Every published notice in this contracting process, newest first.

  1. Contract Award Notice

    10 June 2025

Contracting authority

  • Servicio Murciano de Salud - Junta de Compras

    Procuring entity

    Espinardo, Spain

    ID_PLATAFORMA: 41261690169929

Get the full picture

AI analysis, bid scoring, and expert strategy for this tender

Skim analyses every tender against your company profile and tells you whether to bid, how to win, and who you are up against.

See which competitors are winning the contracts you're chasing.

15-minute call. We'll pull the win data on your real pipeline and show you what Skim does with it.

Awarded: Suministro de Medicamentos con principio activo Eculizumab para el tratamiento de la Hemoglobinuria Paroxística Nocturna y Síndrome Hemolítico Urémico con destino a Centros Sanitarios dependientes del Servicio Murciano de Salud. — won by 2 adjudicatarios AMGEN S.A.: 1911000 y SAMSUNG BIOEPIS NL B.V:1820000 — Skim